Metagen Therapeutics

About:

Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.

Website: https://www.metagentx.com/

Twitter/X: metagen_tx

Top Investors: SMBC Venture Capital, JAFCO, Mizuho Capital, Nippon Venture Capital, JIC Venture Growth Investments

Description:

Metagen Therapeutics is a drug discovery and medical business company which utilizes microbiome science. The company promotes drug discovery and medical business using microbiome science. Metagen Therapeutics is a joint venture between Fast Track Initiative Co., Ltd. and Keio Innovation Co., Ltd.

Total Funding Amount:

1.93B JPY

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Tsuruoka, Yamagata, Japan

Founded Date:

2020-01-17

Contact Email:

contact(AT)metagentx.com

Founders:

Dai Ishikawa, Shinji Fukuda, Taku Nakahara, Takuji Yamada

Number of Employees:

11-50

Last Funding Date:

2023-06-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai